VENIXXA
Natural health product licensed in Canada
- Licence holder
- Servier Canada Inc.
- NPN or DIN-HM
- 80078651
- Status
- Active licence
- Licence date
- 22 June 2017
- Revision date
- 26 February 2026
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bioflavonoïdes d'agrumes Source : Bioflavonoïdes d'agrumes Potency : 90 % Diosmin | 500 milligramme | Not calculated |
| Bioflavonoïdes d'agrumes Source : Bioflavonoïdes d'agrumes Potency : 10 % Flavonoids expressed as hesperidin | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Oxyde de fer jaune, Gélatine, Lauryl sulfate de sodium, Hydroxypropylméthylcellulose, Stéarate de magnésium, Glycérol, Oxyde de fer (Fe2O3), Dioxyde de titane, Glycolate d'amidon sodique, Talc, Macrogol 6 000
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes avec Maladie veineuse chronique | Not specified | 1 Comprimé | 2 days |
| Adults with Acute hemorrhoidal episode | Not specified | minimum: 2 Comprimé ; maximum: 3 Comprimé | 2 days |
| Adultes with Hémorroïdes | Not specified | 1 Comprimé | 2 days |
Uses authorised in Canada
Helps to reduce lower leg edema associated with mild-to moderate chronic venous disease. Helps to relieve signs and symptoms of mild-to-moderate chronic venous disease such as varicose and spider veins, pain in the legs, sensation of heaviness, sensation of swelling and functional discomfort. Helps to reduce signs and symptoms associated with hemorrhoids, such as anal discharge, bleeding, discomfort, inflammation (proctitis), itching (pruritus), pain, redness (erythema), sensation of needing to pass stools (tenesmus) and swelling (edema). Helps to reduce the duration, intensity and recurrence of acute hemorrhoidal episodes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Treatment should be avoided during pregnancy and breastfeeding. If symptoms of chronic venous disease persist or worsen consult a health care practitioner. If you suffer, or experience inflammation of the skin, thrombophlebitis or subcutenious induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency or disorder, consult a health care practitioner. If symptoms persist or worsen, or if acute hemorrhoidal episode persists after 7 days, consult a health care practitioner. If you are taking prescription medication, consult a healthcare practitioner prior to use. If hemorrhoids are accompanied by rectal bleeding (bloody stools sometimes look like black tar), or if you experience change in bowel habit, consult a healthcare practitioner.
- Effets indésirables connus
Hypersensitivity/allergy, gastrointestinal discomfort, dizziness, headaches, malaise and skin reactions have been known to occur; in which case, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80078651
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.